Menu
Back to User profile » Dr Novaria Sari Dewi Panjaitan
Papers published by Dr Novaria Sari Dewi Panjaitan:
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment [Letter]
Panjaitan NSD, Handayani S, Lestari CSW
Diabetes, Metabolic Syndrome and Obesity 2024, 17:1725-1726
Published Date: 15 April 2024
Response to Article “Kaempferia parviflora Extracellular Vesicle Loaded with Clarithromycin for the Treatment of Helicobacter pylori Infection” [Letter]
Yuliandari P, Maha MS, Panjaitan NSD
International Journal of Nanomedicine 2024, 19:2993-2994
Published Date: 23 March 2024
Burnout Syndrome Among Critical Care Health Providers in Saudi Arabia [Letter]
Handayani S, Lestari CSW, Panjaitan NSD
Journal of Multidisciplinary Healthcare 2024, 17:1023-1024
Published Date: 8 March 2024
Exploring Female Relatives of Patients with Hemophilia’ Awareness, Attitudes, and Understanding Towards Genetic Testing [Letter]
Panjaitan NSD, Maha MS, Rinendyaputri R
Journal of Multidisciplinary Healthcare 2024, 17:879-880
Published Date: 29 February 2024
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
Lienggonegoro LA, Dany F, Panjaitan NSD
Neuropsychiatric Disease and Treatment 2023, 19:1899-1900
Published Date: 1 September 2023
Response on Article “A Sustained-Release Nanosystem with MRSA Biofilm-Dispersing and -Eradicating Abilities Accelerates Diabetic Ulcer Healing” [Letter]
Panjaitan NSD, Hartanti MD, Rinendyaputri R
International Journal of Nanomedicine 2023, 18:4633-4634
Published Date: 14 August 2023
Thoughtful Discussion on Article “Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo” [Letter]
Hidayat S, Isnawati R, Panjaitan NSD
Drug Design, Development and Therapy 2023, 17:1433-1434
Published Date: 15 May 2023
A Response to Article “Selenium-Modified Chitosan Induces HepG2 Cell Apoptosis and Differential Protein Analysis” [Letter]
Mariya SS, Mariya S, Panjaitan NS
Cancer Management and Research 2023, 15:407-408
Published Date: 10 May 2023
Response to Article “Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells” [Letter]
Maha MS, Panjaitan NSD
Clinical, Cosmetic and Investigational Dermatology 2023, 16:749-750
Published Date: 28 March 2023
Critical Response: “Does the Mutation of Cancer Driver Genes IDH1/2 and CD204 Influence Cancer Metabolism and Tumor Associated Macrophage Recruitment in Tumor Microenvironment” [Letter]
Panjaitan NSD, Handayani S, Dewi RM
Biologics: Targets and Therapy 2023, 17:41-42
Published Date: 20 March 2023
Critical Response to Article “Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis” [Letter]
Rinendyaputri R, Panjaitan NSD
Drug Design, Development and Therapy 2023, 17:837-838
Published Date: 20 March 2023
Questions Regarding Variants in ADIPOQ in Maternal Circulating Adipokine Profile in Gestational Diabetes Mellitus [Letter]
Panjaitan NSD, Mariya SS, Hasugian AR
Journal of Multidisciplinary Healthcare 2023, 16:429-430
Published Date: 14 February 2023
Thoughtful Response on “MRI-based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma” [Letter]
Panjaitan NSD, Lestari CSW, Maha MS
Journal of Multidisciplinary Healthcare 2023, 16:275-276
Published Date: 26 January 2023
Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
Panjaitan NSD, Lestari CSW, Maha MS
Diabetes, Metabolic Syndrome and Obesity 2022, 15:3889-3890
Published Date: 14 December 2022
A Response to Article “Anti-Diarrheal Activity of Hydromethanolic Crude Extract and Solvent Fractions of Acacia Seyal (Fabaceae) Roots in Mice” [Letter]
Panjaitan NSD, Fitriana F, Handayani S
Clinical Pharmacology: Advances and Applications 2022, 14:111-112
Published Date: 29 November 2022
Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter]
Panjaitan NSD, Lienggonegoro LA, Nikmah UA
OncoTargets and Therapy 2022, 15:1417-1418
Published Date: 25 November 2022
A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter]
Panjaitan NSD
OncoTargets and Therapy 2022, 15:1405-1406
Published Date: 22 November 2022
A Response to Research Article “Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains” [Letter]
Panjaitan NSD, Lestari CSW
Infection and Drug Resistance 2022, 15:6065-6066
Published Date: 21 October 2022
A Response to Article “Distribution of Mcr-1 Harboring Hypervirulent Klebsiella Pneumoniae in Clinical Specimens and Lytic Activity of Bacteriophage KpnM Against Isolates” [Letter]
Panjaitan NSD, Lestari CSW
Infection and Drug Resistance 2022, 15:6007-6008
Published Date: 19 October 2022